Hantavirus Outbreak Triggers Cautious Biotech Stock Rally
Biotech stocks such as Moderna, Inovio, and Novavax rose on hantavirus outbreak headlines, but analysts cautioned the moves are sentiment-driven with limited revenue potential; Moderna noted ongoing preclinical hantavirus work with USAMRIID, while the WHO said the public health risk remains low and the incident appears contained.